Human phospho-Lck (Y394) Antibody (755103)

R&D Systems | Catalog # MAB7500

R&D Systems

Key Product Details

Validated by

Biological Validation

Species Reactivity

Validated:

Human

Cited:

Human, Mouse, Transgenic Mouse

Applications

Validated:

Western Blot, Immunocytochemistry

Cited:

Western Blot, Immunocytochemistry

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2B Clone # 755103
Loading...

Product Specifications

Immunogen

Phosphopeptide containing the human Lck Y394 site
Accession # P06239

Specificity

Detects human Lck when phosphorylated at Y394. Due to high sequence homology, this antibody may cross-react with phosphorylated members of the Src family.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2B

Scientific Data Images for Human phospho-Lck (Y394) Antibody (755103)

Detection of Human Phospho-Lck (Y394) antibody by Western Blot.

Detection of Human Phospho-Lck (Y394) by Western Blot.

Western blot shows lysates of Jurkat human acute T cell leukemia cell line and Ramos human Burkitt's lymphoma cell line untreated (-) or treated (+) with 1 mM Pervanadate (PV) for 5 minutes. PVDF membrane was probed with 0.1 µg/mL of Mouse Anti-Human Phospho-Lck (Y394) Monoclonal Antibody (Catalog # MAB7500) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for Phospho-Lck (Y394) at approximately 56 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Phospho-Lck (Y394) antibody in Jurkat Human Cell Line by Immunocytochemistry (ICC).

Phospho‑Lck (Y394) in Jurkat Human Cell Line.

Lck phosphorylated at Y394 was detected in immersion fixed Jurkat human acute T cell leukemia cells treated with (upper panel) or without (lower panel) Pervanadate using Mouse Anti-Human Phospho-Lck (Y394) Monoclonal Antibody (Catalog # MAB7500) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). Specific staining was localized to cell surfaces and cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
Detection of f2taqonjiwgimc7btuo5.jpg by Western Blot

Detection of f2taqonjiwgimc7btuo5.jpg by Western Blot

Pretreatment with LCK inhibitor followed by LCKi-cisplatin treatment attenuates tumor burden, and treated tumors indicate decreased P-LCK. NSG mice were injected with CP70-luciferase transfected cells followed by pretreatment with LCKi (6 mice) or vehicle (24 mice) for 14 days. LCKi mice were then co-treated with LCKi and cisplatin, and vehicle mice were randomized to further treatment with vehicle, cisplatin, saracatinib, or combination (6 mice per arm) (a). IVIS imaging was obtained on a weekly basis to assess tumor growth (b). IVIS luminescence was corrected to baseline for each arm and assessed over time (c) and at the experimental endpoint (d). Tumors from NSG mice were extracted, and protein lysates were prepared and immunoblotted for protein expression of P-LCK (Y394) and T-LCK. Fold changes of protein expression are shown in the figure, with values normalized to vehicle control. GAPDH was used as a loading control (e). Two tumors per condition were probed, with at least three technical replicates performed. Mouse body weight at day 7, 21, and 28 were obtained for each arm, with weights shown as fold change from baseline (f) Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33888137), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of fmtslydn7u79t2logeav.jpg by Western Blot

Detection of fmtslydn7u79t2logeav.jpg by Western Blot

Loss of phosphorylation at S224 and S241 prevents LAT tyrosine phosphorylation, binding to the signalosome, and cytokine production(A) JLAT transductants with DNA-PKcs phosphorylation sites 224 or 241 mutated, stimulated with 5 μg/mL alpha CD3/CD28 for 24 h, are unable to produce IL-2, as assessed by ELISA. Data are represented as mean ± SEM.(B) Western blot analysis of ZAP70 tyrosine phosphorylation events on LAT (Y132, 171, and 191) in resting or 2-min alpha CD3/CD28 (5 μg/mL) TCR-stimulated JLAT transductants. Following 2-min alpha CD3/CD28 stimulation, tyrosine’s 132, 171, and 191 are phosphorylated in WT and S224A JLAT transductants but not in S241A and S2A JLAT transductants.(C) ImageJ quantification of band intensity shows that WT and S224A LAT have tyrosine phosphorylation (132, 171, and 191) 9-fold higher than the S241 and S2A transductants, with one dot representing one experiment. Data are represented as mean ± SEM.(D) ZAP70 tyrosine phosphorylation of residues 132, 171, and 191 on LAT is blocked with pan-PI3K inhibitor LY294002 (20 μM) but not with selective PI3K inhibitors in WT LAT transduced JLAT T cells.(E) ImageJ quantification of band intensity shows tyrosine phosphorylation (132, 171, and 191) 2.5-fold lower in WT LAT-transduced JLAT T cells treated with LY294002 compared to other inhibitors tested, with one dot representing one experiment. Data are represented as mean ± SEM.Representative blots from n = 3 independent experiments. One-factor ANOVA plus Tukey’s multiple comparisons to determine statistical significance ( alpha = 0.05, *p < 0.05, **p < 0.01, ***p < 0.0005, and ****p < 0.0001). Image collected and cropped by CiteAb from the following open publication (https://linkinghub.elsevier.com/retrieve/pii/S2211124725015682), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human phospho-Lck (Y394) Antibody (755103)

Application
Recommended Usage

Immunocytochemistry

8-25 µg/mL
Sample: Immersion fixed Jurkat human acute T cell leukemia cell line treated with Pervanadate

Western Blot

0.1 µg/mL
Sample: Jurkat human acute T cell leukemia cell line and Ramos human Burkitt's lymphoma cell line treated with Pervanadate

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Sterile PBS to a final concentration of 0.5 mg/mL. For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: Lck

Lck (p56lck) is a 56 kDa cytosolic phosphoprotein within the Src family of non-receptor tyrosine kinases. The 509 amino acid (aa) human Lck contains an SH3 domain (aa 61-121), an SH2 domain (aa 127-224) and a protein kinase domain (aa 251-259). A short (363 aa) isoform contains alternate sequence starting at aa 348, while a 539 aa isoform contains inserted sequence after aa 321. Lck interacts with T cell CD4 and CD8 molecules and plays a pivotal role in regulating T cell activation. It can be overexpressed in cancers and functions as an oncogene. Y394 is the major site for autophosphorylation that enhances kinase activity, while Y505 is the major phosphorylation site for negative regulation.

Long Name

Lymphocyte Protein Tyrosine Kinase

Alternate Names

Hck-3, Lcktkr, LSTRA, p56lck, pp58lck, YT16

Entrez Gene IDs

3932 (Human); 16818 (Mouse); 313050 (Rat)

Gene Symbol

LCK

UniProt

Additional Lck Products

Product Documents for Human phospho-Lck (Y394) Antibody (755103)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human phospho-Lck (Y394) Antibody (755103)

For research use only

Citations for Human phospho-Lck (Y394) Antibody (755103)

Customer Reviews for Human phospho-Lck (Y394) Antibody (755103)

There are currently no reviews for this product. Be the first to review Human phospho-Lck (Y394) Antibody (755103) and earn rewards!

Have you used Human phospho-Lck (Y394) Antibody (755103)?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 for a review with an image

$10/€7/£6/$10CAN/¥1110 for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies
Loading...